Donaperminogene seltoplasmid

塞多明基

Report date: 2024/09/19 15:03:38

Base Information

Drug NameDonaperminogene seltoplasmid
Drug Alias NameDonaperminogene seltoplasmid改良肝细胞生长因子基因治疗 - ViroMedHepatocyte growth factor gene therapy-ViroMed修饰肝细胞生长因子基因治疗 - ViroMed重组人肝细胞生长因子裸质粒注射液 +[17] 
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionHGF gene transferenceAngiogenesis inducersHepatocyte growth factor stimulants
TargetsHepatocyte growth factor
Therapy Area/IndicationsDiabetic peripheral neuropathyUlcerIschemia +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth KoreaMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesViromed
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Haiwang Bio-Pharmaceutical Co LtdBeijing Northland Biotech Co LtdHelixmith Co Ltd +[4] 
Inactive CompaniesThe Brigham and Women's Hospital
Active IndicationsDiabetic peripheral neuropathyUlcerIschemia +[9] 
Inactive IndicationsDiabetic FootMyocardial InfarctionMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A